Fingerprint
Dive into the research topics of 'Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically